Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Day

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Scientific Reports|March 4, 2022
Maturation of the internal auditory canal and posterior petrous bone with relevance to lateral and posterolateral skull base approachesRobert C Rennert, Michael G Brandel, Jeffrey A Steinberg, et al.
Journal of the American College of Cardiology|July 2, 2013
Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm studyBrian D Powell, Leslie A Saxon, John P Boehmer, et al.
The American Journal of Cardiology|March 11, 2008
Frequency of helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiographyT Jared Bunch, John D Day, Jeffrey L Anderson, et al.
Pacing and Clinical Electrophysiology : PACE|May 9, 2009
Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independentlyMark A Crandall, Benjamin D Horne, John D Day, et al.
Journal of Cardiovascular Electrophysiology|November 14, 2017
Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of strokeT Jared Bunch, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Electrophysiology|March 3, 2023
Response to "Delay in AF ablation costs lives"Andrew J Sessions, Heidi T May, Brian G Crandall, et al.
Frontiers in Oncology|May 13, 2021
Brain Tumor Biobank Development for Precision Medicine: Role of the NeurosurgeonEmilie Darrigues, Benjamin W Elberson, Annick De Loose, et al.
Journal of Cardiovascular Electrophysiology|January 14, 2023
Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes in patients with and without structural heart diseaseAndrew J Sessions, Heidi T May, Brian G Crandall, et al.
Heart, Lung & Circulation|July 1, 2017
Risk Factor Management and Atrial Fibrillation Clinics: Saving the Best for Last?Rajiv Mahajan, Rajeev K Pathak, Anand Thiyagarajah, et al.
Journal of Cardiovascular Electrophysiology|August 29, 2017
Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patientsVictoria Jacobs, Heidi T May, Tami L Bair, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Scientific Reports|March 4, 2022
Maturation of the internal auditory canal and posterior petrous bone with relevance to lateral and posterolateral skull base approachesRobert C Rennert, Michael G Brandel, Jeffrey A Steinberg, et al.
Journal of the American College of Cardiology|July 2, 2013
Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm studyBrian D Powell, Leslie A Saxon, John P Boehmer, et al.
The American Journal of Cardiology|March 11, 2008
Frequency of helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiographyT Jared Bunch, John D Day, Jeffrey L Anderson, et al.
Pacing and Clinical Electrophysiology : PACE|May 9, 2009
Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independentlyMark A Crandall, Benjamin D Horne, John D Day, et al.
Journal of Cardiovascular Electrophysiology|November 14, 2017
Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of strokeT Jared Bunch, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Electrophysiology|March 3, 2023
Response to "Delay in AF ablation costs lives"Andrew J Sessions, Heidi T May, Brian G Crandall, et al.
Frontiers in Oncology|May 13, 2021
Brain Tumor Biobank Development for Precision Medicine: Role of the NeurosurgeonEmilie Darrigues, Benjamin W Elberson, Annick De Loose, et al.
Journal of Cardiovascular Electrophysiology|January 14, 2023
Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes in patients with and without structural heart diseaseAndrew J Sessions, Heidi T May, Brian G Crandall, et al.
Heart, Lung & Circulation|July 1, 2017
Risk Factor Management and Atrial Fibrillation Clinics: Saving the Best for Last?Rajiv Mahajan, Rajeev K Pathak, Anand Thiyagarajah, et al.
Journal of Cardiovascular Electrophysiology|August 29, 2017
Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patientsVictoria Jacobs, Heidi T May, Tami L Bair, et al.
Pageof 13